Gilead's Advancing Access^® Program Is Here
to Help Your Patients

By following this link, you are leaving this Gilead website. Gilead provides these links as a convenience. But these sites are not controlled by Gilead. Gilead is not responsible for their content or your use of them.

×

If you are uninsured, have a prescription for, and need to get started immediately with one of these Gilead medications, click on the appropriate link below.

BIKTARVY® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg) tablets

TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) tablets

DESCOVY® (emtricitabine 200 mg/tenofovir alafenamide 25 mg) tablets

GENVOYA® (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg) tablets

ODEFSEY® (emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg) tablets

They may qualify for free medication. Once eligibility is established, you can print a pharmacy medication card immediately so your patient can take it, along with their prescription, to the pharmacy of their choice. You can also submit the prescription electronically to the patient's pharmacy of choice.

Go to the Advancing Access HCP portal and enroll your patient for immediate access to their pharmacy medication card, if approved.